What is SiftMed?
Founded in 2020, SiftMed operates at the intersection of advanced artificial intelligence and medical informatics. The company provides a sophisticated platform designed to ingest, organize, and analyze disparate medical records, enabling healthcare providers to access actionable insights with unprecedented speed. By automating the synthesis of patient data, SiftMed addresses the critical industry challenge of information overload, allowing clinicians to focus on patient care rather than administrative data management. Its market position is defined by its focus on high-fidelity data processing, which is essential for modernizing legacy healthcare infrastructure and supporting the transition toward data-centric clinical environments.
How much funding has SiftMed raised?
SiftMed has raised a total of $5.5M across 1 funding round:
Seed
$5.5M
Seed (2026): $5.6M with participation from Pelorus Venture Capital, Sandpiper Ventures, The51, and Staircase Ventures
Key Investors in SiftMed
Pelorus Venture Capital
Pelorus VC is a venture capital fund established in 2015, focused on investing in pre-seed innovation companies in Newfoundland and Labrador, partnering closely with founders to commercialize bold ideas.
Sandpiper Ventures
Sandpiper Ventures is an early-stage venture capital fund focused on empowering women investors and founders to disrupt the traditional venture capital landscape by identifying high-performing, tech-enabled companies.
The51
The51 is a Canadian-based wealth creation platform building a movement to tap into underutilized female wealth and invest it in talented female entrepreneurs and venture funds.
What's next for SiftMed?
Looking ahead, the strategic deployment of the $5.6M will likely focus on scaling SiftMed's engineering capabilities and expanding its market reach across North America. As the company transitions from its initial development phase into a period of rapid commercialization, the focus will shift toward deepening product-market fit and enhancing the platform's interoperability with existing electronic health record systems. The backing from a consortium of specialized venture firms provides not only the necessary liquidity for growth but also access to a robust network of expertise in founder development and operational scaling. This capital injection serves as a catalyst for SiftMed to solidify its role as a foundational technology provider in the evolving digital health ecosystem.
See full SiftMed company page
